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HYPERTRIGLYCERIDEMIC WAIST PHENOTYPE: A MARKER OF CARDIOMETABOLIC RISK 








Hypertriglyceridemic waist phenotype in patients with arterial 
hypertension was examined. Patients were categorized into 3 pheno­
type groups based on waist circumference means and plasma triglyc­
eride levels: group 1 included patients (n=10) with normal waist cir­
cumference (< 90cm in men and < 85 cm in women) and elevated 
plasma triglyceride levels (> 1.7 mmol/l); group 2 included patients 
(n=25) with increased waist circumference (> 90 cm in men and > 85 
cm in women) and normal triglyceride level (< 1.7 mmol/l); group 3 
include patients (n=66) with increased waist circumference (circum­
ference > 90 cm in men and > 85 cm in women) and increased plasma 
triglyceride levels (> 1.7 mmol/l) that is with hypertriglyceridemic 
waist phenotype.
The result of our clinical study of patients with arterial hyper­
tension showed that hypertriglyceridemic waist phenotype was asso­
ciated with elevated SBP, DBP levels; increased body mass, BMI; in­
creased pro-inflammatory cytokine -  IL-18 activity; highest gluco- 
metabolic risk and atherogenic metabolic risk profile. Our results can 
suggest that hypertriglyceridemic waist phenotype is a simple and 
inexpensive marker to help identify patients with high cardiometabol- 
ic risk profile, and also can be used as a simple screening approach to 
predict development of type 2 diabetes mellitus.
Key words: hypertriglyceridemic waist phenotype, glycemic pro­
file, interleukins, cardiometabolic risk, arterial hypertension.
Objective. Cardiovascular disease (CVD) has been a leading cause of morbidity and mortality 
all over the world. Epidemiologic and metabolic studies found strong association of obesity, especially 
of abdominal type of body fat distribution, to metabolic and cardiovascular pathology. Metabolic syn­
drome (MS) -  a cluster of abdominal obesity, impaired glucose tolerance, dyslipidemia, and arterial 
hypertension is closely associated with further development of type 2 diabetes mellitus (type 2 DM) 
and CVD, and therefore has been used to identify subjects with high cardiometabolic risk [1-3]. There 
is increasing evidence that hypertriglyceridemic waist phenotype is stronger and more valid marker of 
cardiovascular risk and a better predictor of CVD than MS [4,5]. Therefore, we examined hypertriglyc- 
eridemic waist phenotype in patients with arterial hypertension.
Design and m ethods. 104 men (n=45, 43.3 %) and women (n=59, 56.7 %) aged 32-80 years 
with arterial hypertension were examined. Systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) levels were measured twice after 5-minute rest in a sitting position using standardized mercury 
sphygmomanometer; than average mean of two measurements were calculated and used as a blood 
pressure level. Anthropometric measurements include: body weight using digital scales and recorded 
to the nearest 0.1 kg. The patient’s height was measured using tape meter. Body mass index (BMI) was 
calculated as weight in kilograms divided by the square of the height in meters (kg/m2). W aist circum­
ference was measured at the umbilicus level, using a tape meter. Fasting blood samples were collected 
for measurements of carbohydrates profile: glucose, insulin, HbAc1 plasma levels, and lipid panel. Cir­
culation plasma levels of proinflammatory cytokine -  interleukin-18 (IL-18) and anti-inflammatory 
cytokine -  interleukin-10 (IL-10) were detected by ELISA. A  hypertriglyceridemic waist phenotype was 
defined as an elevated waist circumference > 90 cm in men and > 85 cm in women along with an ele­
vated plasma triglyceride content > 1.7 mmol/l.
Results. Patients were categorized into 4 phenotype groups based on waist circumference 
means and plasma triglyceride levels. There were only 3 patients who had normal waist circumference 
and normal triglyceride levels. Therefore, were excluded them from the study and continue statistical 
analysis in 3 phenotype groups based on hypertriglyceridemic waist phenotype criteria: group 1 in­
cluded patients (n=10) with normal waist circumference (< 90cm in men and < 85 cm in women) and 
elevated plasma triglyceride levels (> 1.7 mmol/l); group 2 included patients (n=25) with increased 
waist circumference (> 90 cm in men and > 85 cm in women) and normal triglyceride level 
(< 1.7 mmol/l); group 3 include patients (n=66) with increased waist circumference (> 90 cm in men
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and > 85 cm in women) and increased plasma triglyceride levels (> 1.7 mmol/l) that is with hypertr i- 
glyceridemic waist phenotype.
Our results suggest that the most of examined patients with arterial hypertension have hyper- 
triglyceridemic waist phenotype. The baseline characteristics of the 3 groups are summarized in Table.
There were no statistically significant differences in patient’s age among comparison groups. 
Patients of group 3 with hypertriglyceridemic waist phenotype had longest duration of arterial hyper­
tension, and the highest blood pressure levels as compared with group 1 and group 2 (p<0.05 in all 
cases).
Table
Baseline characteristics of the patients with arterial hypertension based 













ence / elevated 
triglyceride levels 
n=66
Age, years 51.18±3.09 62.72±1.13 56.98±0.88
Hypertension duration, 
years 6.36±1.24 9.68±1.28 10.00±0.98
SBP, mmHg 142.91±0.99 159.44±3.23 166.50±1.83
DBP, mmHg 91.64±0.93 100.32±1.48 100.89±0.94
Height, m 1.72±0.02 1.66±0.02 1.70±0.01
Body mass, kg 72.18±3.08 84.16±2.81 89.15±1.72
BMI, kg/m2 23.95±0.91 30.21±1.00 31.05±0.61
ОТ 79.45±1.90 104.04±2.19 104.38±1.34
IL-18, pg/ml 167.73±7.21 172.40±5.61 178.97±2.38
IL-10, pg/ml 87.44±2.03 77.97±1.07 88.79±0.64
Glucose, mmol/l 5.14±0.31 5.92±0.35 6.95±0.12
Insulin, mkU/ml 12.52±2.79 12.31±1.41 14.66±0.95
HOMA 2.90±0.70 2.95±0.33 3.32±0.27
FIRI 2.64±0.64 2.92±0.38 3.04±0.25
HbA1c, % 5,74±0,38 7,18±0,49 6,12±0,20
Total cholesterol, mmol/l 6.08±0.49 4.58±0.13 5.95±0.17
Triglyceride, mmol/l 2.82±0.13 0.99±0.06 2.71±0.05
HDL cholesterol, mmol/l 1.04±0.09 1.27±0.03 1.12±0.04
LDL cholesterol, mmol/l 3.76±0.41 2.87±0.11 3.60±0.14
Patients of group 3 characterized by higher body mass and BMI means than patients with low ­
er waist circumference and plasma triglyceride levels.
A  growing body of evidence suggests that MS is associated with a chronic, low-grade inflam­
mation and that several pro-inflammatory cytokines are elevated in parallel with an increasing number 
of MS components, whereas anti-inflammatory cytokines are consistently lower. IL-18 is a member of 
IL-1 superfamily, in several studies has been associated with obesity, insulin resistance, arterial hyper­
tension, and dyslipidemia that are with components of MS [6,7]. In our study plasma IL-18 levels were 
statistically significant highest (p<0.05) in group 3 hypertensive patients with hypertriglyceridemic 
waist phenotype (Fig. 1).
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Figure 1. Plasma IL-18 levels in patients with arterial hypertension based 
on hypertriglyceridemic waist phenotype
Anti-inflammatory cytokine -  IL-10 is also involved in pathogenesis of cardiometabolic disor­
ders. The results of several studies show that circulating level of potent anti-inflammatory cytokine IL- 
10 are elevated in obese women and that low IL-10 levels are associated with MS. Our result showed 
highest IL-10 plasma levels in group 3 hypertensive patients with hypertriglyceridemic waist pheno­
type (Fig. 2), but these differences were statistically insignificant (p>0.05).
Figure 2. Plasma IL-10 levels in patients with arterial hypertension based 
on hypertriglyceridemic waist phenotype
Patients in group 3 had significantly higher fasting plasma glucose, insulin levels, and means 
of insulin resistance index HOMA and FIRI (p<0.05) compared with patients in group 1 and group 2 
that confirmed results of previous studies which showed predictive role of hypertriglyceridemic waist 
phenotype in development of type 2 diabetes mellitus.
Plasma total cholesterol and LDL cholesterol levels were higher, and HDL cholesterol levels 
were lower in group 3 and group 1 as compared with group 2 patients with arterial hypertension.
Conclusions. The result of our clinical study of patients with arterial hypertension showed 
that hypertriglyceridemic waist phenotype was associated with elevated SBP, DBP levels; increased 
body mass, BMI; increased pro-inflammatory cytokine -  IL-18 activity; highest glucometabolic risk 
and atherogenic metabolic risk profile.
In conclusion, our results can suggest that hypertriglyceridemic waist phenotype is a simple 
and inexpensive marker to help identify patients with high cardiometabolic risk profile, and also can 
be used as a simple screening approach to predict development of type 2 diabetes mellitus.
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ГИПЕРТРИГЛИЦЕРИДЕМИЧЕСКОЙ ТАЛИИ ФЕНОТИП: 
МАРКЕР КАРДИОМЕТАБОЛИЧЕСКОГО РИСКА 
У ПАЦИЕНТОВ С АРТРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ
Изучено фенотип гипертриглицеридемической талии у боль­
ных с артериальной гипертензией. Больных разделили на три феноти­
пические группы на основании значений окружности талии и уровня 
триглицеридов: в 1 группу вошли пациенты (n=10) с нормальной 
окружностью талии (< 90 см у мужчин и < 85 см у женщин) и повы­
шенным уровнем триглицеридов в плазме (> 1,7 ммоль/л); во 2 группу 
вошли больные (n=25) с увеличенной окружностью талии (> 90 см у 
мужчин и > 85 см у женщин) и нормальным уровнем триглицеридов 
(< 1,7 ммоль/л); 3 группа состояла из пациентов (n=66) с повышенным 
показателем окружности талии (> 90 см у мужчин и > 85 см у женщин) 
и повышенным уровнем триглицеридов (> 1,7 mmol/l) то есть с фено­
типом гипертриглицеридемической талии.
Результаты нашего клинического исследование покали, что 
фенотип гипертриглицеридемической талии ассоциирован с повы­
шенным уровнем САД, ДАД; с увеличением массы тела, ИМТ; усилени­
ем активности провоспалительного цитокина -  ИЛ-18; наиболее высо­
ким глюкометаболическим риском и атерогенным метаболическим 
риском. Наши результаты могут свидетельствовать о том, что фенотип 
гипертриглицеридемической талии является простым и доступным 
маркером, помогающим выявлять пациентов с высоким кардиометабо- 
лическим риском, а также, может быть использован в качестве не 
сложного скринингового подхода для предупреждения развития са­
харного диабета 2 типа.
Ключевые слова: фенотип гипертриглицеридемической талии, 
гликемический профиль, интерлейкины, кардиометаболический риск, 
артериальная гипертензия.
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